Kidney Spleen Treatment Of Functional Dyspepsia

Objectives:Through the observation of functional dyspepsia patients with kidney and spleen qi spleen France France, mosapride dispersible tablets combined Deanxit in the treatment of functional dyspepsia patients with symptoms before and after comparison to determine kidney spleen France clinical effect.Materials and Methods:According to May 2006 meeting in Los Angeles developed digestive functional gastrointestinal disorders in Rome III criteria, and in the light (China Association of Integrative Medicine Professional Committee of Digestive Diseases 2003, 'Chongqing) of functional dyspepsia in Chinese and Western Medicine Diagnosis and treatment program (draft) diagnostic criteria, and belong to the spleen and stomach qi deficiency type FD patients,90 patients were randomly divided into treatment group spleen kidney, spleen qi and the control group and medicine control group (mosapride dispersible tablets combined deanxit) all 30 cases, kidney spleen treatment groups:(Codonopsis 15g Poria 15g Chinese yam 15g Atractylodes 15g medlar 12g Polygonatum 15g licorice 6g); spleen qi and the control group:(Moka 6g Amomum 6g dried tangerine peel 10g Pinellia 6g Changium 15g Atractylodes 15g Poria 15g licorice 6g); western medicine control group (mosapride dispersible tablets 5mg tid, deanxit a bid); three groups for 8 weeks, two groups of Chinese medicine Shuijianbi, day 1, morning and evening hours service. Respectively before and after treatment in patients with symptom score, observed kidney Spleen symptoms of functional dyspepsia improve the situation.Results:(1) three groups with comparable pre-treatment condition, kidney spleen treatment group, the total efficiency and spleen qi control group, western medicine control group there was no significant difference (p> 0.05), while in the clinical cure rate was significantly higher than the above Qi Jian spleen control group, with the western medicine group there was no significant difference;(2) three groups of symptoms compared with those before treatment after treatment difference was statistically significant (p<0.05). However, poor sleep or anxiety symptom improvement, the kidney spleen treatment group was significantly better than the control group, spleen qi, the difference was statistically significant (p<0.05).Conclusions:(1) Kidney Spleen can improve FD symptoms, and can significantly improve emotional disorders caused by poor sleep, or anxiety, in which symptoms improvedon the more traditional method is better spleen qi. (2) Kidney and Spleen Qi and Spleen Prescription Prescription FD treatment had no significant toxic side effects and adverse reactions.